"What's particularly striking is the sluggishness in consumption...
Category:
International News
Latest
Wipro invests $66 million in US insurtech Aggne
EAST BRUNSWICK, N.J/TAMPA, Fla/ BENGALURU: “The Aggne team has a...
Canada’s Fairfax denies Muddy Waters’ short report in expanded rebuttal
Fairfax said Muddy Waters neither called it nor wrote to it, and...
UK asks regulator to assess AZ-Oxford vaccine amid questions
The step comes amid questions about preliminary results from trials of the jab, after the company and the university acknowledged that the most encouraging part of their findings stemmed from a dosing error.
UK Health Secretary Matt Hancock said he had asked the Medicines and Healthcare Products Regulatory Agency (MHRA) to determine whether the vaccine “meets rigorous safety standards.”
Suspected North Korean hackers targeted COVID vaccine maker AstraZeneca –
Cyberattacks against health bodies, vaccine scientists and drugmakers have soared during the COVID-19 pandemic as state-backed and criminal hacking groups scramble to obtain the latest research and information about the outbreak.
Western officials say any stolen information could be sold for profit, used to extort the victims, or give foreign governments a valuable strategic advantage as they fight to contain a disease that has killed 1.4 million people worldwide.
New Zealand’s Ardern set to declare climate emergency
“We’ve always considered climate change to be a huge threat to our region, and it is something we must take immediate action on,” Ardern said, according to state broadcaster TVNZ.If a climate emergency is passed, New Zealand would join countries like Canada, France and Britain that have taken the same course to focus efforts on tackling climate change.
Action needed to spur British government-backed pandemic insurance, says project chair
Stephen Catlin, chairman of the Pandemic Re Steering Committee, a British industry group, said he had hoped in early June that a launch would be possible in 2021.“But as time went on, it became clear that the complexity was going to slow it down,” Catlin, who is also chairman and CEO of insurer Convex, told the Reuters Events Future of Insurance Europe conference.
Aviation bodies seek airport slots waiver for much of 2021
The draft proposal to be issued jointly by IATA, airports body ACI and slot coordinators, calls on regulators to extend the current waiver of rules requiring airlines to use 80% of their take-off and landing windows or else cede some to rivals.
CEO says AstraZeneca likely to run new global Covid vaccine trial: Report
In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses.
The biggest threat to Covid-19 vaccination could be fake news and misinformation
“The coronavirus disease is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected,” the WHO said.
“At the same time, the technology we rely on to keep connected and informed is enabling and amplifying an infodemic that continues to undermine the global response and jeopardises measures to control the pandemic.”
Covid vaccine rush in China raises fears of booming black market
As developers from AstraZeneca Plc to Pfizer Inc. near the finish line for their coronavirus vaccines, nations are preparing for the challenge of rolling them out, with inevitable supply shortages fueling concerns about inequitable distribution and even the emergence of illegal markets. One place where vaccine delivery is already being road-tested is China, which has allowed local developers’ shots for emergency use since mid-year.
Europe’s drugs watchdog expects first marketing application for coronavirus vaccine in days
The European Medicines Agency (EMA) did not name the company it expects to file the application, but Pfizer Inc and BioNTEch are the most advanced in the regulatory process among the three companies that have published late-stage trial data for their vaccines.
World agonises over new COVID curbs as infections approach 60 million
an approved vaccine is unlikely to be widely available for months while scientists insist on the continued need for vigilance and politicians consider curbs for Christmas amid a second wave of the pandemic.